Understanding Fat-Derived Cell Therapy for Osteoarthritis: A Research Review

Akkawi Ibrahim, Draghetti Maurizio, Zmerly Hassan · Acta Biomedica · 2020

Your Own Fat Contains Powerful Healing Cells

If you have osteoarthritis, you know the frustration of joint pain that limits your daily activities. This research review examined a promising treatment approach: using regenerative cells from your own body's fat tissue. These cells, called mesenchymal stromal cells (MSCs), have a remarkable ability to reduce inflammation and support tissue repair. Fat tissue is an especially rich source of these healing cells—containing about 500 to 1,000 times more regenerative cells than bone marrow.

Why Fat Tissue Outperforms Bone Marrow as a Cell Source

Doctors have long known that bone marrow contains regenerative cells. However, harvesting bone marrow can be painful and yields relatively few cells. This review explains why fat tissue offers several advantages:

  • Fat contains far more regenerative cells per sample

  • The harvesting procedure causes less pain

  • Cells from fat multiply faster in the body

  • The procedure is simpler and more accessible

  • Donor age affects fat-derived cells less than bone marrow cells

How These Cells Work to Relieve Joint Pain

The review explains two ways fat-derived cells help osteoarthritic joints. First, they can transform into cartilage-producing cells called chondrocytes. Second, and perhaps more importantly, they release special molecules that trigger healing responses throughout the joint. These molecules reduce inflammation, prevent cell death, and help new blood vessels form to nourish damaged tissue.

Thirteen Studies Show Consistent Pain Relief

The researchers analyzed 13 clinical studies involving patients treated with minimally processed fat-derived cells. The studies followed patients for six months to three years. Across nearly all measured outcomes, patients experienced significant improvements in pain and joint function. One study tracked 110 patients, while others ranged from four to 52 participants. Patient ages varied widely, with most studies including people in their fifties and sixties.

Minimal Processing Keeps Cells in Their Natural State

Traditional methods of extracting cells from fat use enzymes, which raises regulatory concerns and may damage the cells. The treatment approach examined in this review uses gentle mechanical processing instead. This keeps the cells in their natural environment—surrounded by the supportive tissue structures they need to function properly. The processed fat can be injected immediately or stored for future use.

Results Across Multiple Joints Look Promising

The reviewed studies examined treatment results for knees, hips, shoulders, and ankles. Knee osteoarthritis received the most attention, but positive outcomes appeared across joint types. Pain scores, function scores, and quality of life measurements all showed meaningful improvement compared to before treatment. Importantly, the studies reported very few complications, suggesting this approach is quite safe.

What This Means for Your Treatment Decision

This comprehensive review confirms that minimally processed fat-derived cell therapy shows genuine promise for osteoarthritis pain and dysfunction. The evidence comes from multiple research teams studying different joints over periods up to three years. While most studies were observational rather than randomized controlled trials, the consistent positive results across diverse patient groups are encouraging. If you're considering this treatment, discuss these findings with your doctor to determine whether it might be appropriate for your specific situation.

Source: Akkawi et al., Acta Biomedica, 2020.

Original Publication

Minimally manipulated adipose derived mesenchymal stromal cells and osteoarthritis: A narrative review

Akkawi Ibrahim, Draghetti Maurizio, Zmerly Hassan · Acta Biomedica · 2020

Human mesenchymal stromal cells (MSCs) have increasingly been used to treat osteoarthritis (OA) related pain and dysfunction, due to their capacity for regeneration and anti-inflammatory effects. Adipose-derived MSCs are characterized by their abundance, ease of access, easy isolation procedures, high lipoaspirate stromal cell production, quicker multiplication of cells, and less pain and morbidity during harvesting. These cells are typically enzymatically derived from adipose tissue but this technique has complicated regulatory problems. To address this problem, a new technique has been created to extract and process adipose tissue without expansion and the use of enzymes to produce autologous minimally manipulated adipose-derived MSCs. Recent studies have confirmed that this treatment is an effective and promising method for treating pain and improving joint function in patients affected by OA with a very low percentage of complications at short to mid-term follow-up.

Related Research